Drospirenone with ethinylestradiol: how this combined pill works
Drospirenone with ethinylestradiol is a combined contraceptive pill, and every licence for this combination in Ireland requires a prescription. Yasmin is one brand; Yasminelle, Yaz and several other products contain the same two substances, some with less oestrogen per tablet. This page explains how you take it, how its risk of blood clots compares with other combined pills, who should not use it, which side effects are common and how a request is assessed.
What the pill contains and how it works
Each tablet combines an oestrogen, ethinylestradiol, with a progestogen, drospirenone. According to section 5.1 of the Yasmin summary of product characteristics (SmPC), it works mainly by stopping ovulation and by changing the lining of the womb.
The indication in section 4.1 is "Oral contraception", and the decision to prescribe should take into account your own risk factors, "particularly those for venous thromboembolism (VTE)". It offers no protection against HIV or any other sexually transmitted infection.
Products with this combination licensed in Ireland
There are 15 licences for drospirenone with ethinylestradiol on the HPRA list of authorised medicines; every one is a film-coated tablet in category B supplied through pharmacies only. Some packs include inactive placebo tablets, as their names show, and come with their own instructions: the leaflet for your product is the one to follow, while this page is based on the Yasmin SmPC.
Not covered here: drospirenone on its own (4 mg) or combined with estetrol or estradiol.
| Strength per tablet | Products on the HPRA list |
|---|---|
| Ethinylestradiol 0.03 mg with drospirenone 3 mg | Yasmin, Dretine, Elvina, Freedo, Ethinylestradiol/Drospirenone Leon Farma (two products, one with placebo tablets) |
| Ethinylestradiol 0.02 mg with drospirenone 3 mg | Yasminelle, Yaz, Alexette, Dretinelle, Elvinette, Freedonel, Veyann, Ethinylestradiol/Drospirenone Leon Farma (two products, one with placebo tablets) |
How to take it
With Yasmin you take one tablet a day at about the same time, in the sequence printed on the blister pack, for 21 days, then have 7 days without tablets. A withdrawal bleed usually starts on day 2 or 3 of the break. When to start, according to section 4.2 of the SmPC:
- No hormonal contraception in the past month: on day 1 of your period.
- From another combined pill: preferably the day after its last active tablet, at the latest the day after its usual break; from a ring or patch, preferably on the day of removal.
- From a progestogen-only method: from a mini pill on any day, from an implant or hormonal coil on the day of removal, from an injection when the next one is due, with condoms for the first 7 days.
- After giving birth: from day 21 to day 28; if you start later, use a barrier method for 7 days, and if you have had sex, pregnancy has to be excluded first or you wait for your first period.
If you are late with a tablet or are unwell
Less than 12 hours late: protection is not reduced, so take the tablet as soon as you remember. If you are more than 12 hours late, protection may be reduced, and the advice depends on the week of the pack. In week 1, take the last missed tablet as soon as you remember, even if that means two at once, and use condoms for the next 7 days; if you had sex in the previous 7 days, pregnancy is possible.
In week 2, take the missed tablet; if the previous 7 were taken correctly, no extra precautions are needed, but after missing more than one, use condoms for 7 days. In week 3, if every tablet in the previous 7 days was taken correctly, the SmPC lets you either start the next pack without a break or stop and have a break of up to 7 days, counting the missed days; if not, start the next pack without a break and use condoms for 7 days.
No bleed in the break after missed tablets means pregnancy has to be considered; see our article on the morning-after pill.
If you vomit in the 3 to 4 hours after a tablet, take a replacement as soon as possible. Severe vomiting or diarrhoea also calls for extra contraception.
Blood clot risk compared with other combined pills
Every combined hormonal contraceptive raises the risk of a blood clot in a vein (VTE) compared with no use. According to section 4.4 of the Yasmin SmPC, pills containing levonorgestrel, norgestimate or norethisterone carry the lowest risk, and drospirenone pills may carry up to twice that risk, so choosing one should follow a discussion of what that means for you.
The risk is highest in the first year you ever use a combined pill and may rise again when you restart after a break of 4 weeks or more. It stays lower than the risk expected in pregnancy or just after birth. The SmPC says a VTE may be fatal in 1 to 2% of cases.
| Group (SmPC section 4.4) | Women out of 10,000 expected to develop a VTE in one year |
|---|---|
| Not using a combined hormonal contraceptive and not pregnant | About 2 |
| Using a combined pill with levonorgestrel | About 6 (range 5 to 7) |
| Using a combined pill with drospirenone | 9 to 12 |
Risk factors the doctor asks about
Your own risk can be far higher than the averages above, and several factors together can add up to more than each alone. Section 4.4 lists:
- a body mass index over 30 kg/m²
- a blood clot, heart attack or stroke in a brother, sister or parent, especially before 50
- major surgery, surgery to the legs or pelvis, or long immobilisation; air travel of more than 4 hours can add to the risk
- age, particularly over 35, and smoking: women over 35 who continue to smoke are advised to use a different method
- high blood pressure, diabetes, heart valve disease, atrial fibrillation, raised blood fats or lupus
- migraine, especially if it becomes more frequent or severe on the pill
- cancer, inflammatory bowel disease or sickle cell disease
- the 6 weeks after giving birth
Who should not take this pill
Section 4.3 of the SmPC lists conditions in which combined pills must not be used; if one appears while you take the pill, it is stopped at once. They include a current or past blood clot, an inherited or acquired clotting tendency, major surgery with long immobilisation, a heart attack, angina, stroke or mini-stroke (TIA), migraine with focal neurological symptoms (aura), diabetes with blood vessel damage, severe high blood pressure and severe abnormal blood fats.
Also on the list: severe liver disease until liver tests are normal, severe kidney failure, liver tumours, cancers influenced by sex hormones, unexplained vaginal bleeding, allergy to an ingredient, and use with certain hepatitis C combination treatments.
Signs of a blood clot: get help urgently
If you notice any of these, phone 112 or 999 or go to your nearest emergency department (ED), and mention there that you are on a combined pill:
- swelling, pain or tenderness in one leg, warmth or discoloured skin
- sudden breathlessness, coughing that may bring up blood, sharp chest pain, severe light-headedness or an irregular heartbeat
- sudden numbness or weakness of the face, arm or leg, trouble speaking, confusion, loss of vision or a sudden severe headache
- pain, pressure or heaviness in the chest or arm, discomfort spreading to the jaw or back, sweating or nausea
Common and less common side effects
Section 4.8 of the SmPC groups the side effects reported with Yasmin by how often they occur. Irregular bleeding or spotting is more likely in the first months. Small rises in blood pressure are reported in many women on combined pills, but clinically relevant rises are rare.
| How often (SmPC section 4.8) | Effects listed |
|---|---|
| Common (1 in 100 to 1 in 10) | Depressed mood, headache, migraine, nausea, menstrual disorders, bleeding between periods, breast pain or tenderness, vaginal discharge, vaginal thrush |
| Uncommon (1 in 1,000 to 1 in 100) | Changes in sex drive, high or low blood pressure, vomiting, diarrhoea, acne, eczema, itching, hair loss, breast enlargement, vaginal infection, fluid retention, weight gain or loss |
| Rare (1 in 10,000 to 1 in 1,000) | Allergic reactions, asthma, reduced hearing, blood clots in a vein or artery, erythema nodosum, erythema multiforme, breast discharge |
Mood changes and depression
Section 4.4 of the SmPC describes depressed mood and depression as well-known side effects of hormonal contraception and warns: "Depression can be serious and is a well-known risk factor for suicidal behaviour and suicide." Contact a doctor if your mood changes or you have symptoms of depression, including shortly after you start. If you feel in crisis, contact one of these:
- In an emergency, phone 112 or 999 or go to your nearest emergency department (ED).
- Samaritans: 116 123 (free, 24 hours a day).
- Pieta: 1800 247 247 (24-hour crisis helpline) or text HELP to 51444.
- Text About It: text HELLO to 50808 (free, 24 hours a day).
Medicines that interact
Medicines that speed up hormone breakdown in the liver can cause breakthrough bleeding or contraceptive failure. The SmPC names barbiturates, bosentan, carbamazepine, phenytoin, primidone, rifampicin, ritonavir, nevirapine and efavirenz, and possibly felbamate, griseofulvin, oxcarbazepine, topiramate and St John's wort. With a short course, add a barrier method during it and for 28 days after; with long-term use, a non-hormonal method is recommended.
With an aldosterone antagonist or a potassium-sparing diuretic, the SmPC advises a potassium check in the first cycle. Ketoconazole and etoricoxib can raise hormone levels, and the pill can lower lamotrigine levels. Tell the doctor about every medicine you use.
Pregnancy, breastfeeding and after birth
This pill is not for use in pregnancy and is stopped if you become pregnant. Combined pills can reduce the amount of breast milk and change its make-up, so the SmPC says they should generally not be recommended until you have completely weaned your baby; a progestogen-only pill such as desogestrel is an option the doctor may discuss. The higher risk of clots in the weeks after birth is taken into account when you restart.
How a request is assessed
Your request begins with a medical questionnaire: in it you tell the doctor which pill you take or want to begin, and describe your health, your family history and which other conditions and medicines you have. There is no video call and no telephone consultation. If the doctor has questions, they ask them in writing in the chat in your account, and you get an email to let you know.
Before you start or restart, the SmPC asks for a full medical history, a check that you are not pregnant, a blood pressure measurement and a physical examination led by its contraindications and warnings. It is for the doctor to judge whether your questionnaire answers are sufficient: he may use the chat to ask for a blood pressure reading taken recently, suggest an assessment in person, or decline.
The prescription, the pharmacy and what it costs
If the doctor issues a prescription, you receive it as a PDF by email. You print the PDF and take the printout to a pharmacy. A pharmacist in Ireland decides whether to dispense a prescription written by a doctor in another EEA country and may decline. This is not an Irish ePrescription and it is not sent through Healthmail.
Our fee covers the doctor's assessment; you pay for the medicine at the pharmacy, at the pharmacy's price. Our fee is shown on the button. We make no claim about whether a medicine dispensed on this prescription counts towards a medical card or the Drugs Payment Scheme. Other methods are compared in our guide to contraception.
Who assesses requests
Each request on this site is assessed in writing by Damian Wojno, a doctor registered in Poland (licence no. 3211301, Regional Medical Chamber in Olsztyn). He is not on the register of the Irish Medical Council.
Is Yasmin prescription only in Ireland?
Yes. "Product subject to prescription which may be renewed" (category B) is how the HPRA lists Yasmin and the 14 other licences for drospirenone with ethinylestradiol, and each of them is supplied only via pharmacies.
What is the difference between Yasmin and Yasminelle?
Both contain 3 mg of drospirenone per tablet; the difference is the oestrogen, with 0.03 mg of ethinylestradiol in Yasmin and 0.02 mg in Yasminelle, and the doctor considers which strength, if any, suits you.
Should I stop the pill before an operation?
For planned major surgery or surgery to the legs or pelvis, the SmPC advises stopping at least four weeks beforehand and restarting two weeks after you are fully mobile, using another method in between; tell your surgeon that you take the pill.
Can a pharmacist refuse to dispense the prescription?
Yes, the pharmacist decides and may decline, for instance if they have doubts about its safety or validity. Guidance from the Pharmaceutical Society of Ireland says that a prescription shown on a phone would not be considered appropriate.
Is the pill free in Ireland?
For people aged 17 to 35, the HSE Free Contraception Service covers contraception prescribed through a GP or clinic that is part of the scheme, with no charge for the GP visit or prescription fees; our service is private, sits outside that scheme and charges a fee for the doctor's assessment.
- HPRA: Yasmin 0.03 mg/3 mg film-coated tablets, product information and SmPC (licence PA1410/023/001)
- Source: HPRA, Human Medicines - Authorised Products (data.gov.ie, CC BY 4.0), licences and legal supply status of drospirenone products
- PSI: Guidance on Dispensing Prescriptions Issued in Another EEA Member State
- HSE: Free Contraception Service
- HSE: Get urgent help for your mental health